Connecticut 2024 2024 Regular Session

Connecticut House Bill HB05488 Introduced / Fiscal Note

Filed 04/10/2024

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
sHB-5488 
AN ACT CONCERNING VARIOUS REVISIONS TO THE PUBLIC 
HEALTH STATUTES.  
 
Primary Analyst: RP 	4/9/24 
Contributing Analyst(s): RDP, DD, LG, ES   
Reviewer: PR 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 25 $ FY 26 $ 
UConn;  UConn Health Ctr. GF - Cost See Below See Below 
Note: GF=General Fund 
  
Municipal Impact: 
Municipalities Effect FY 25 $ FY 26 $ 
Various Municipalities STATE 
MANDATE
1
 
- Cost 
See Below See Below 
  
Explanation 
The bill makes various changes to the public health statutes and 
results in the following fiscal impact. 
Section 3 results in annual costs beginning in FY 25 to the University 
of Connecticut (UConn), the University of Connecticut Health Center, 
and various municipalities. It requires ambulances to carry glucagon 
nasal powder for emergency medical services, affecting some 
municipalities
2
 as well as UConn and UConn Health, which both own 
                                                
1
State mandate is defined in Sec. 2-32b(2) of the Connecticut General Statutes, "state 
mandate" means any state initiated constitutional, statutory or executive action that 
requires a local government to establish, expand or modify its activities in such a way 
as to necessitate additional expenditures from local revenues. 
2
Less than 40% of municipalities own ambulances, with most towns being serviced by 
non-profit ambulance agencies.  2024HB-05488-R000423-FN.DOCX 	Page 2 of 2 
 
 
ambulances. Glucagon nasal powder has an approximate per unit cost 
of $300 and will need to be replaced about every 18 months unless 
administered sooner.
3
 
This section is not anticipated to result in a cost to municipal police 
departments, even though many police officers are certified emergency 
medical responders (EMR). The bill does not specify that EMRs or their 
vehicles need to be equipped with glucagon nasal powder. 
The Out Years 
The annualized ongoing fiscal impact identified above would 
continue into the future subject to the shelf-life and usage of glucagon 
nasal powder and inflation. 
                                                
3
These costs may not be fully recouped through ambulance billing, as such billing rates 
are set by the Department of Public Health and are not typically itemized.